Suppr超能文献

一大组低促性腺激素性性腺功能减退患者中促性腺激素释放激素受体突变的患病率。

The prevalence of gonadotropin-releasing hormone receptor mutations in a large cohort of patients with hypogonadotropic hypogonadism.

作者信息

Bhagavath Balasubramanian, Ozata Metin, Ozdemir I C, Bolu Erol, Bick David P, Sherins Richard J, Layman Lawrence C

机构信息

Division of Reproductive Endocrinology, Infertility, and Genetics, Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, Georgia, USA.

出版信息

Fertil Steril. 2005 Oct;84(4):951-7. doi: 10.1016/j.fertnstert.2005.04.029.

Abstract

OBJECTIVE

To determine the prevalence of GNRH receptor (GNRHR) gene mutations in a large cohort of patients with idiopathic hypogonadotropic hypogonadism (IHH).

DESIGN

Molecular analysis and genotype/phenotype correlations.

SETTING

University molecular reproductive endocrinology laboratory.

PATIENT(S): North American and Turkish patients with IHH.

INTERVENTION(S): DNA from 185 IHH patients were subjected to denaturing gradient gel electrophoresis for exons and splice junctions of the GNRHR gene. Variant fragments were sequenced.

MAIN OUTCOME MEASURE(S): GNRHR mutations were characterized and compared with the phenotype. The prevalence of GNRHR mutations was also determined.

RESULT(S): Three of 185 (1.6%; confidence interval [CI] 0.3%-4.7%) total IHH patients demonstrated compound heterozygous GNRHR mutations. All three were identified from a cohort of 85 normosmic patients (3.5%, CI 0.73%-7.5%), and none were demonstrated in hyposmic or anosmic IHH patients. GNRHR mutations were identified in 1 of 15 (6.7%; CI 0.2%-32.0%) families with at least two affected siblings, and in 2 of 18 (11.1%; CI 1.4%-34.7%) normosmic females. None were found in presumably autosomal dominant families.

CONCLUSION(S): GNRHR mutations account for approximately 3.5% of all normosmic and 7%-11% of presumed autosomal recessive IHH, suggesting that additional genes play an important role in normal puberty. We believe this to be the largest GNRHR gene mutation analysis performed to date in a population of IHH patients.

摘要

目的

确定一大群特发性低促性腺激素性性腺功能减退症(IHH)患者中促性腺激素释放激素受体(GNRHR)基因突变的患病率。

设计

分子分析及基因型/表型相关性研究。

地点

大学分子生殖内分泌实验室。

患者

北美和土耳其的IHH患者。

干预措施

对185例IHH患者的DNA进行变性梯度凝胶电泳,检测GNRHR基因的外显子和剪接位点。对变异片段进行测序。

主要观察指标

对GNRHR突变进行特征分析并与表型进行比较。同时确定GNRHR突变的患病率。

结果

185例IHH患者中有3例(1.6%;置信区间[CI] 0.3%-4.7%)表现为复合杂合GNRHR突变。这3例均来自85例嗅觉正常的患者群体(3.5%,CI 0.73%-7.5%),嗅觉减退或嗅觉缺失的IHH患者中未发现此类突变。在至少有两名患病同胞的15个家庭中有1个家庭(6.7%;CI 0.2%-32.0%)检测到GNRHR突变,在18例嗅觉正常的女性中有2例(11.1%;CI 1.4%-34.7%)检测到该突变。在推测为常染色体显性遗传的家庭中未发现此类突变。

结论

GNRHR突变约占所有嗅觉正常的IHH患者的3.5%,以及推测为常染色体隐性遗传的IHH患者的7%-11%,这表明其他基因在正常青春期中发挥重要作用。我们认为这是迄今为止在IHH患者群体中进行的最大规模的GNRHR基因突变分析。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验